301
Participants
Start Date
July 31, 2008
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
lamictal
Flexible Dosing
GSK Investigational Site, Mount Kisco
GSK Investigational Site, Philadelphia
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Baltimore
GSK Investigational Site, Roanoke
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Smyrna
GSK Investigational Site, Jacksonville
GSK Investigational Site, Gainesville
GSK Investigational Site, Winter Park
GSK Investigational Site, Orlando
GSK Investigational Site, Tampa
GSK Investigational Site, Bradenton
GSK Investigational Site, Dothan
GSK Investigational Site, Columbus
GSK Investigational Site, Toledo
GSK Investigational Site, Cleveland
GSK Investigational Site, Cincinnati
GSK Investigational Site, Cincinnati
GSK Investigational Site, Indianapolis
GSK Investigational Site, Rochester
GSK Investigational Site, Fargo
GSK Investigational Site, Libertyville
GSK Investigational Site, Naperville
GSK Investigational Site, Saint Charles
GSK Investigational Site, Overland Park
GSK Investigational Site, Wichita
GSK Investigational Site, Lincoln
GSK Investigational Site, Shreveport
GSK Investigational Site, Dallas
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Scottsdale
GSK Investigational Site, Albuquerque
GSK Investigational Site, San Diego
GSK Investigational Site, Stanford
GSK Investigational Site, Kirkland
GSK Investigational Site, Seattle
GSK Investigational Site, Boston
GSK Investigational Site, Boston
GSK Investigational Site, Springfield
GSK Investigational Site, Worcester
GSK Investigational Site, Piscataway
GSK Investigational Site, Stony Brook
Lead Sponsor
GlaxoSmithKline
INDUSTRY